Research released at a major US cancer conference reveals that several new targeted therapies have shown promise against advanced cancers of the blood, lungs, ovaries, and thyroid. Among them is an oral drug called ibrutinib, made by Pharmacyclics. It was found to be "highly active" against chronic lymphocytic leukemia and extended survival in some patients whose cancers did not respond to the standard treatment, chemotherapy. The drug works by blocking ...Sunday, 1 June 2014
Hope Against Aggressive Cancer Demonstrated in Targeted Therapies
Research released at a major US cancer conference reveals that several new targeted therapies have shown promise against advanced cancers of the blood, lungs, ovaries, and thyroid. Among them is an oral drug called ibrutinib, made by Pharmacyclics. It was found to be "highly active" against chronic lymphocytic leukemia and extended survival in some patients whose cancers did not respond to the standard treatment, chemotherapy. The drug works by blocking ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment